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BACKGROUND AND PURPOSE
Exposure to an ototoxic level of an aminoglycoside can result in hearing loss. In this we study investigated the otoprotective
efficacy of dexamethasone (DXM), melatonin (MLT) and tacrolimus (TCR) in gentamicin (GM)-treated animals and cultures.
EXPERIMENTAL APPROACH
Wistar rats were divided into controls (treated with saline); exposed to GM only (GM); and three GM-exposed groups treated
with either DXM, MLT or TCR. Auditory function and cochlear surface preparations were studied. In vitro studies of oxidative
stress, pro-inflammatory cytokine mRNA levels, the MAPK pathway and caspase-3 activation were performed in organ of Corti
explants from 3-day-old rats.
KEY RESULTS
DXM, MLT and TCR decreased levels of reactive oxygen species in GM-exposed explants. The mRNA levels of TNF-a, IL-1b
and TNF-receptor type 1 were significantly reduced in GM + DXM and GM + MLT groups. Phospho-p38 MAPK levels
decreased in GM + MLT and GM + TCR groups, while JNK phosphorylation was reduced in GM + DXM and GM + MLT
groups. Caspase-3 activation decreased in GM + DXM, GM + MLT and GM + TCR groups. These results were consistent with
in vivo results. Local treatment of GM-exposed rat cochleae with either DXM, MLT or TCR preserved auditory function and
prevented auditory hair cell loss.
CONCLUSIONS AND IMPLICATIONS
In organ of Corti explants, GM increased oxidative stress and initiated an inflammatory response that led to the activation of
MAPKs and apoptosis of hair cells. The three compounds tested demonstrated otoprotective properties that could be
beneficial in the treatment of ototoxicity-induced hearing loss.
Abbreviations
ABRs, auditory brainstem responses; AP-1, activating protein-1; DAPI, 4′,6-diamidino-2-phenylindole; dB, decibel;
DPOAEs, distortion product otoacoustic emissions; DXM, dexamethasone; ERKs, FITC, fluorescein isothiocyanate; GM,
gentamicin; HCs, hair cells; hROS, highly reactive oxygen species; IHCs, inner hair cells; IL1R1, IL receptor type 1; iNOS,
inducible nitrogen oxide syntase; L-NAME, L-nitro-arginine methyl ester; LNCaP, lymph node carcinoma of the
prostate; MLT, melatonin; MP, miniosmotic pumps; NBT, nitroblue tetrazolium; ns, not significant; OHCs, outer hair
cells; PD, PD98059, 2-(2-amino-3-methoxyphenyl) chromen-4-one; ROS, reactive oxygen species; RT-PCR, reverse
transcription PCR; S, saline; SCI, spinal cord injury; SOD, superoxide dismutase; SPL, sound pressure level; TCR,
tacrolimus; TNFRSF1A, TNF receptor type 1; TRITC, tetramethyl rhodamine isothiocyanate
BJP British Journal ofPharmacology
DOI:10.1111/j.1476-5381.2012.01890.x
www.brjpharmacol.org
1888 British Journal of Pharmacology (2012) 166 1888–1904 © 2012 The Authors
British Journal of Pharmacology © 2012 The British Pharmacological Society
Introduction
Aminoglycoside antibiotics are used clinically for treating
tuberculosis as well as other illnesses produced by aerobic
Gram-negative bacteria (Bertolaso et al., 2003; Nordang and
Anniko, 2005; Xie et al., 2011). Although the use of these
agents has declined in recent years, aminoglycosides are still
widely used in developing countries, mostly due to their cost,
effectiveness and availability. Unfortunately, this practice has
resulted in a high incidence of aminoglycoside-associated
hearing loss in these countries. There is evidence that ami-
noglycosides can enter sensory hair cells via their mechan-
otransduction channels and once inside accumulate within
the lysosomes. Scanning electron microscopic observations
range from disorganization and fusion of stereocilia at low
doses of an aminoglycoside to complete hair cell loss at
higher doses (Alharazneh et al., 2011; Cunningham and Tan,
2011). The antibacterial effect of aminoglycosides is achieved
through the inhibition of protein synthesis at the ribosome
level and the pore-forming effect that this class of antibiotics
has on cell membranes. Positively charged aminoglycoside
molecules are attracted to the negatively charged outer
plasma membrane of affected cells including those that make
up the cochlear sensory receptor. Using an energy-dependent
process, aminoglycoside molecules enter cells, where they
initiate the formation of free radicals using a pathway that
has been implicated in the pathology of several inner ear
disorders. The generation of reactive oxygen species (ROS)
involves the formation of an aminoglycoside iron complex,
which then catalyses the production of ROS from unsaturated
fatty acids. This is noteworthy because several reports have
concluded that the generation of ROS is linked to ototoxicity
of the aminoglycosides due to the ability of these free radicals
to promote both apoptotic and necrotic cell death (Ylikoski
et al., 2002; Rybak and Ramkumar, 2007; Cunningham and
Tan, 2011). One signalling enzyme activated by aminoglyco-
sides via ROS is JNK, an enzyme of the MAPK family signal-
ling pathway, which has been shown to contribute to the
apoptosis of damaged cells (Davis, 2000). One of the down-
stream targets of JNK is the transcription factor activating
protein-1 (AP-1), which is of special interest considering that
gentamicin (GM) treatment of organ of Corti explants is
known to result in increased AP-1 activity in outer hair cells
(OHCs; Pirvola et al., 2000; Ylikoski et al., 2002; Wang et al.,
2003).
The aim of the present study was to determine the
protective efficacy of three compounds (i.e. dexametha-
sone, DXM; tacrolimus, TCR; melatonin, MLT) against
GM-initiated damage to the cochlea using both in vivo and in
vitro experiments. These three compounds are currently used
clinically. DXM has long been employed by physicians to
limit the effect of cochlear injury on hearing thresholds, while
TCR is currently used for inhibiting transplant rejection, and
MLT is a common dietary supplement for the treatment of
insomnia. These compounds have different properties, but all
have the potential to prevent hair cell (HC) death by acting at
different points in a cell death pathway in which GM treat-
ment of organ of Corti explants leads to pro-inflammatory
cytokines and ROS production with subsequent activation of
MAPK signalling. MLT is a potent antioxidant and free radical
scavenging hormone, while DXM is an anti-inflammatory
and anti-allergy drug that is known to inhibit AP-1 (González
et al., 2000). TCR, used for its immunosuppressive effect, is a
MAPK/JNK pathway inhibitor and therefore should limit the
formation of AP-1 (Kaminska, 2005).
Methods
In vitro studies
Organ of Corti explants Three-day-old (P-3) rats of the Wistar
strain of laboratory rats (Harlan Interfauna Iberica, Barcelona,
Spain and Charles River Laboratories, Wilmington, MA, USA)
were anaesthetized with ice for 30 min. All animal experi-
ments were conducted in accordance with the guidelines
established by the European Union on Animal Care (CEE
Council 86/609). Housing conditions and experimental pro-
cedures were approved and monitored by the Institutional
Ethics Committee of the University of Valencia, Spain. In
addition, animal experiments performed at the University of
Miami Ear Institute with P-3 rats were in accordance with the
Guidelines for the Care and Use of Laboratory Animals of the
National Institutes of Health (NIH Publications no. 80-23,
revised 1996) and in accordance with the University of
Miami, Internal Animal Care and Use Committee, protocol #
11–086.
Organ of Corti explants were dissected en bloc and subse-
quently placed in serum-free media consisting of Dulbecco’s
modified Eagle’s medium supplemented with glucose (final
concentration at 6 g·L-1), 1% of N-1 supplement (Sigma
Aldrich, St. Louis, MO, USA) and penicillin G (30 U·mL-1).
RNA extraction and real-time reverse transcription (RT)-
PCR. Twenty-four organ of Corti explants for each real-time
RT-PCR experiment were cultured for 24 h, under the follow-
ing conditions: saline (S); GM (100 mM); GM (100 mM) + DXM
(50 mM); DXM (50 mM); GM (100 mM) + MLT (50 mM); MLT
(50 mM); GM (100 mM) + TCR (50 mM); TCR (50 mM). Three
independent experiments were carried out (n = 3 explants/
condition). RNA was extracted with TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA) according to the manufacturer’s
protocol. RNA purity and concentration were determined by
the absorbance at 260 nm and 280 nm using Nano Drop
ND-1000 (Thermo Fisher Scientific, Waltham, MA, USA).
cDNA was synthesized using iScript kit (Bio-Rad, Hercules, CA,
USA). Quantitative real-time PCR was performed in duplicate
by using iQ SYBR Green Supermix (Bio-Rad) on iCycler Real-
Time CFX96 Detection System (Bio-Rad). The mRNA level was
normalized by housekeeping gene b-actin. The primers were
designed based on the cDNA sequences obtained from
Ensembl Genome Browser (http://www.ensembl.org). The
primers set used were: TNF-a 5′-AACTCGAGTGACAAGC
CCGTAG-3′ and 3′-GTACCACCAGTTGGTTGTCTTTGA-5′
(ENSRNOT00000001110); TNF receptor superfamily member
1A (TNFRSFIA) 5′-GAACACCGTGTGTAACTGCC-3 and 3′-
ATTCCTTCACCCTCCACCTC-5′ (ENSRNOT00000048529);
IL-1b 5′-ACCCAAGCACCTTCTTTTCC-3′ and 3′-AGACAGC
ACGAGGCATTTTT-5′ (ENSRNOT00000006308); IL1R1 5′-TG
ACCCAGGATCCACGATAC-3′ and 3′-AGTCAGGAACTGG
GTATAC-5′ (ENSRNOT00000019673); inducible nitric oxide
synthase (iNOS or NOS2) 5′-CTGGGACTGCACAGA ATGTTC
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C-3′ and 3′-TTTGCCTCTTTGAAGGAGCC-5′ (ENSRNOT0000
0016133); b-actin 5′-CGTTGACATCCGTAAAGACC-3′ and
3′-AGCCACCAATCCACACAGAG-5′ (Sigma Aldrich). Real-
time PCR was carried out to 40 cycles at 95°C, 61°C and 72°C,
50 s each. Melting curves were also performed to ensure primer
specificity and evaluate for any contamination. Relative
changes in mRNA levels of genes were assessed using the 2(-DDCT)
method and normalized to the housekeeping gene b-actin and
then to the expression levels of control organ of Corti
explants. The formula used to calculate % inhibition was
[(x–y)/x]*100, where x is levels of mRNA in GM group and y is
levels of mRNA in treatment groups.
ERK 1/2, p-ERK 1/2; p38 MAPK, p-p38 MAPK; JNK, p-JNK-
ELISAs. Eighty organ of Corti explants for each ELISA experi-
ment were cultured for 24 h, under the following condi-
tions: S; GM (100 mM); GM (100 mM) + DXM (50 mM); DXM
(50 mM); GM (100 mM) + MLT (50 mM); MLT (50 mM); GM
(100 mM) + TCR (50 mM); TCR (50 mM) and then incubated at
37°C in 5% CO2 with 95% relative humidity. Three indepen-
dent experiments were carried out (n = 4 explants/condition).
As recommended by the manufacturer, PD98059, an inhibitor
of MAPK kinases and anisomycin (both from Sigma Aldrich),
an activator of JNK/SAPK and p38 were used as controls for the
ELISA assays of the organ of Corti explants. Each specimen was
placed in an individual well of a 96-well culture plate, and ERK
1/2, phosphorylated-ERK 1/2; p38 MAPK, phosphorylated-
p38; JNK, phosphorylated JNK proteins were detected using
the RayBio® Cell-based ERK1/2 ELISA sampler kit (Ray Biotech,
Inc, Norcross, GA, USA) as described in the manufacturer’s
protocol and quantified at 450 nm wavelength light using a
VersaMax™ Microplate Reader (Molecular Devices, Sunny-
vale, CA, USA). The supernatant was removed, the tissues were
washed three times with PBS and the proteins were quantified
by Bradford’s method (Bio-Rad). In order to normalize the data
obtained for each organ of Corti explant, the results are
presented as the ratio of ELISA absorbance at 450 nm/Bradford
absorbance at 595 nm.
Assessment of antioxidant enzyme levels. Ninety-six organ
of Corti were cultured for 24 h in either S; GM (100 mM);
GM (100 mM) + DXM (50 mM); DXM (50 mM); GM
(100 mM) + MLT (50 mM); MLT (50 mM); GM (100 mM) + TCR
(50 mM); TCR (50 mM). Specimens were placed in PBS con-
taining phosphatase and proteinase inhibitors cocktail
(Thermo Fisher Scientific, Pittsburgh, PA, USA) on ice and the
cells were lysed with the aid of a Misonix XL-2000 series
sonicator (Misonix, Farmingdale, NY, USA). The samples were
centrifuged at 14 000¥ g, 15 min at 4°C and the supernatants
were collected. The activity of superoxide dismutase (SOD)
was measured by monitoring the rate of inhibition of
nitroblue tetrazolium dye (NBT) reduction (Kono, 1978).
Briefly, 10 mL of supernatant was mixed with 0.1 mM EDTA
solution containing 50 mM sodium carbonate pH 10, 0.6%
Triton X-100 and 20 mM hydroxylamine hydrochloride
pH 6. The reaction started by adding 90 mM NBT (all reactives
from Sigma Aldrich) and the rate of NBT reduction was
recorded every 20 s for 2 min at 560 nm in a SpectraMax
190™ Microplate Reader (Molecular Devices). One enzyme
unit was expressed as inverse of the amount of protein (mg)
required to inhibit the reduction rate by 50% in 1 min.
Catalase activity was assayed by the method of Luck
(1971); 10 mL of supernatant was mixed with 50 mM sodium
phosphate buffer pH 7 and the reaction started by adding
30 mM H2O2 and the changes in absorbance were recorded
every 20 s for 2 min at 240 nm in a SpectraMax 190™
Microplate Reader. Enzyme activity was calculated using
the molar extinction coefficient of H2O2 (0.071 M-1·cm-1).
One unit of catalase activity was defined as mM H2O2
decomposed·min-1·mg-1 protein.
The levels of NO in the supernatants were measured by
the method of Griess (1879; Sigma Aldrich). The absorbance
was measured at 490 nm and the results were expressed in
mM·mg-1 protein.
Total proteins were measured in the supernatants by Brad-
ford’s method and were used to normalize the data obtained
from each experiment.
ROS detection. Twenty organ of Corti explants (n = 4
explants per group) were cultured for 24 h. The groups
were S; GM (500 mM); GM (500 mM) + DXM (50 mM); GM
(500 mM) + MLT (50 mM); GM (500 mM) + TCR (50 mM). Then
CellROX Deep Red (5 mM, Invitrogen) was added to each well
and incubated at 37°C for 30 min. The samples were then
washed three times with PBS fixed in 4% paraformaldehyde,
1% methanol in 0.1 M PBS for 20 min. The explants were
washed three times in PBS and subsequently incubated in 5%
normal goat serum (Sigma Aldrich), 1% Triton X-100 (Fluka)
in PBS for 30 min at 25°C, then were incubated with fluores-
cein isothiocyanate (FITC)-labelled phalloidin for 45 min at
25°C. After being washed, the organ of Corti explants were
incubated in 600 nM 4′,6-diamidino-2-phenylindole (DAPI)
solution (Sigma Aldrich) for 5 min at 25°C following three
additional washes with de-ionized H2O and transferred to a
glass slide with mounting medium, cover slipped and viewed
under a confocal Zeiss Axiovert 700 microscope. ImageJ
1.45h (http://imagej.nih.gov/ij) software was used for pro-
cessing and analysing the images. Red signal intensity was
measured and background was subtracted. The size of the
region of interest was the same for all images and the bright-
ness was in the range of 0 to 255 arbitrary units.
Cleaved caspase-3 immunofluorescent labelling. Thirty organ of
Corti explants (n = 6 explants/condition) were cultured in the
same conditions described above. The groups were S; GM;
GM + DXM; GM + MLT; GM + TCR. The tissues were then
fixed in 4% paraformaldehyde, 1% methanol in 0.1 M PBS for
48 h at 4°C. The explants were washed three times in PBS and
subsequently incubated in 5% normal goat serum, 1% Triton
X-100 in PBS for 30 min at 25°C. The organ of Corti explants
were then incubated with anti-cleaved caspase-3 (Asp175)
rabbit polyclonal antibody (Cell Signaling Technology, MA,
USA) at a 1:200 dilution overnight at 4°C. After being washed
with PBS, the tissues were incubated with secondary antibody
tetramethyl rhodamine isothiocyanate (TRITC)-labelled goat
anti-rabbit IgG (Invitrogen) at a 1:200 dilution for 90 min at
25°C. The tissues were then washed in PBS three times and
incubated with FITC-labelled phalloidin for 45 min at 25°C.
After being washed, the organ of Corti explants were incu-
bated in 600 nM DAPI (Sigma) solution for 5 min at 25°C
following three additional washes with de-ionized H2O and
transferred to a glass slide with mounting medium, cover
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slipped and viewed under a confocal Zeiss Axiovert 700 micro-
scope. ImageJ 1.45h (http://imagej.nih.gov/ij) software was
used for processing and analysing the images. Red signal
intensity was measured as described previously.
In vivo studies
Experimental subjects. All animal care and experimental pro-
cedures were conducted in accordance with the guidelines
established by the European Union on Animal Care (CEE
Council 86/609). Housing conditions and experimental pro-
cedures were approved and monitored by the Institutional
Ethics Committee of the University of Valencia, Spain.
Twenty-five male (n = 5 rats for each group) Wistar rats weigh-
ing 220–250 g from Harlan Interfauna Iberica (Barcelona,
Spain) were used. The rats were fed a standard diet ad libitum
and were kept on a 12 h light–dark cycle. The ambient noise
level in the housing facility was 35–45 dB sound pressure level
(SPL).
Damage protocol. During surgery, the animal’s body tem-
perature was maintained at 36.5–37.5°C with the aid of a
heating pad. Animals were anaesthetized with isoflurane (4%
for induction and then 2%, Aerrane, Baxter, and Norfolk,
UK), buprenorfine (0.05 mg·kg-1, Buprex, Schering-Plough,
Madrid, Spain) was the analgesic. The depth of anaesthesia
was assessed by paw pinch reflex, in which the toe of the
rat was pinched between the fingers to see a withdrawal
response by the animal. Also a corneal reflex was used during
the surgical process in order to (a) not to touch non-sterile
areas (such us the paws) and (b) this was closer to the surgical
area. All surgical procedures where carried out under a stage
3, plane 2 level of anaesthesia. Under aseptic conditions,
temporal bones were exposed via a post auricular approach.
Tympanic bullae were exposed and holes were made with an
18G needle. In the left ears, the tip of the catheters were
placed in the round window membrane niches of each
cochlea, these catheters were attached to mini-osmotic
pumps (MP, Alzet, model 2001, Cupertino, CA, USA) that
were implanted s.c. under the skin of the rat’s back between
the scapulae. In the right ears 2 mm2 pieces of gelfoam were
placed in the round window membrane niches. The animal
treatment groups were S (MP: 200 mL of saline; gelfoam:
40 mL of saline); GM (MP: 10 mg of GM in 200 mL of saline;
gelfoam: 10 mg of GM in 40 mL of saline); GM + DXM;
GM + MLT; and GM + TCR (MP: 10 mg of GM and DXM,
MLT or TCR respectively, with each at 500 mM final concen-
tration in 200 mL of saline; gelfoam: 10 mg of GM and DXM,
MLT or TCR, respectively, with each at 500 mM final concen-
tration in 40 mL of saline) (GM, DXM and MLT from Sigma
Aldrich; TCR from LC Laboratories, Woburn, MA, USA). The
MP catheter was attached to the bone of the bulla, which was
sealed with tissue adhesive and the skin was sutured. After
7 days, the MPs were removed and the remaining mixture of
GM and respective otoprotective compound was subjected to
HPLC analysis under the following conditions: 74:26
methanol-H2O, 0.007% trifluoracetic acid, pump L-6200,
detector L-7455, pre-column and column Lichrospher C18
(Merck Hitachi, Damstadt, Germany). At 7 days, all three
compounds tested were found to be stable in the presence of
GM (data not shown).
Auditory function studies. An otoscopic examination was per-
formed on the rats’ tympanic membranes on each testing day
to rule out possible middle ear pathologies. Observation of
any middle ear pathology would exclude an animal from the
study. Measurements of auditory function were carried out
under brief anaesthesia with isoflurane before GM challenge
and on post-exposure days 0, 10, 15 and 20.
Determination of distortion product otoacoustic emissions
(DPOAEs, DPgrams). The DPOAEs were recorded and analy-
sed with the aid of a Navigator-Pro (Bio-logic, Natus, IL, USA)
cochlear emission analyser. The DPOAEs were recorded at
fixed stimulus levels (L1 = L2 = 70 dB SPL), with an f2/f1 ratio
of 1.22 and three points per octave for f2 ranging from
1453 Hz to 10 kHz.
Auditory brainstem response recordings (ABRs). Three stainless
steel needle electrodes were placed as follows: (1) subdermal
over the vertex; and (2) over the right and (3) left mastoids of
each animal. The ABR stimulus was a 100 ms click presented
at a rate of 21.4/s. ABR thresholds were recorded by attenu-
ating the click stimulus 5 dB stepwise until no reproducible
response could be recorded. The responses to 1000 acoustic
stimuli were then averaged. The signal from the electrodes
was amplified with the aid of Navigator-Pro fitted with pass
filters with a range of 150 Hz to 3 kHz.
Morphological study. Histological preparation and cytococh-
leogram: the rats were deeply anaesthetized with an i.p. injec-
tion of pentobarbital (100 mg·kg-1, Dolethal, Vetoquinol,
France). The cochleae were removed, fixed with 10% formalin
in 0.1 M phosphate buffer at pH 7.4, decalcified in 1 M form-
aldehyde with 2.7 M formic acid and then the organ of Corti
surface preparations were dissected and stained with FITC-
labelled phalloidin (Sigma Aldrich). Inner and outer hair cells
(IHCs and OHCs respectively) were examined with the aid of a
Nikon Eclipse E600 microscope (Nikon Instruments Europe
B.V., Amstelveen, the Netherlands) and counted in 0.15 mm
segments of organ of Corti sensory epithelia and were aver-
aged from 2–3 consecutive segments from the apex to the base
of each cochlea to obtain the cytocochleograms.
Statistical analysis
One-way ANOVA test was used for ABR threshold and gene
expression experiments and for the assessment of the results
of antioxidant enzyme activity. For the rest of the experi-
ments a two-way ANOVA test was employed. Both ANOVA sta-
tistical analyses were followed by a Bonferroni post-test for
multiple comparisons. The data are expressed as mean  SD
and a P-value < 0.05 was considered significant. All calcula-
tions were performed on a computer equipped with Graph
Pad v 4.00 software for Windows® (GraphPad Software, Inc.
La Jolla, CA, USA).
Results
In vitro studies
Gene expression. As it is shown in Figure 1A, TNF-a was
up-regulated in the GM-only group of organ of Corti explants,
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Figure 1
Gene expression analysis of two pro-inflammatory cytokines and their receptors (A–D) and of iNOS (E) in organ of Corti exposed to GM.
Histograms on the left present mRNA levels of the genes studied in organ of Corti explants exposed to GM + treatment with either DXM, MLT
or TCR compared to GM group explant expression levels. Histograms on the right column present mRNA levels of the genes studied in explants
treated with either DXM, MLT or TCR-only in the absence of GM and compared to S group explant expression levels. mRNA levels corresponding
to (A) TNF-a, (B) TNFRSF1A, (C) IL-1b, (D) IL1R1, (E) iNOS. Expression levels are presented as mean values  SD; one-way ANOVA followed by
Bonferroni test; n = 9 explants per group in duplicates; *P < 0.05, **P < 0.01, ***P < 0.001.
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while treatment of GM-challenged explants with DXM, MLT
and TCR reduced the mRNA levels of this cytokine. TNF-a was
down-regulated in DXM-only organ of Corti explants com-
pared with S control group. Similarly, the levels of mRNA for
TNFRSF1A were reduced in the treatment groups GM + DXM
and GM + TCR when compared with GM-only group of organ
of Corti explants (Figure 1B). Exposure to GM induced an
increase in IL-1bmRNA levels that were reduced in GM + DXM
treatment group, and also in the GM + MLT and GM + TCR
groups (Figure 1C). Interestingly, mRNA levels of IL-1b were
enhanced in the organ of Corti explants exposed to MLT only
when compared to the S group explant value. IL1R1 mRNA
levels were not changed by the treatments, but the levels of
this cytokine receptor were increased in the DXM group
compared to the values of the S treatment group (Figure 1D).
Exposure of the organ of Corti to GM alone did not affect the
mRNA levels of the inducible form of NOS (Figure 1E).
ERK 1/2, p-ERK 1/2; p38 MAPK, p-p38 MAPK; JNK, p-JNK-
ELISAs. Treatment of the organ of Corti explants with GM
did not induce a significant increase in the phosphorylation
of ERK1/2 compared to the S-treated control explant values
(Figure 2A). However, treatment of GM-exposed organ of
Corti explants with DXM, MLT or TCR induced an increase
in phospho-ERK1/2 levels. A decrease in ERK1/2-values was
observed in the MLT and TCR-only treated groups when
compared with the S group, while in the DXM alone treated
explants the levels of phospho-ERK1/2 increased.
Phospho-p38 MAPK levels (Figure 2B) increased in the
GM-only treated group of explants compared with the S
group. The p-38 levels and its phosphorylated form were
decreased in the GM + DXM, GM + MLT or GM + TCR groups
of explants compared to the GM-alone group.
Phospho(p)-JNK levels increased in organ of Corti
explants exposed to GM only when compared with the S
group. A decrease in JNK and p-JNK levels was observed in
GM + DXM; GM + MLT; and GM + TCR-treated explants
(Figure 2C) when compared with the GM-alone explant
group. The levels of the p-JNK were higher in the MLT-only
treated group.
Assessment of antioxidant enzymes. SOD activity decreased
in organ of Corti explants exposed to GM, while an increase in
SOD activity that reached S group levels occurred in GM +
DXM, GM + MLT and GM + TCR-treated groups of explants
(Figure 3A). In organ of Corti explants not exposed to GM, the
levels of the SOD activity were higher in DXM-only and
MLT-only treated groups of explants compared to the levels for
this enzyme present in the S explants group, while the TCR-
only group of explants showed a decrease in SOD activity.
Treatment of organ of Corti explants with GM only
reduced catalase activity compared with S explant group
levels. An increase of catalase activity occurred in
GM + DXM, GM + MLT and GM + TCR-treated explant
groups compared with catalase levels in the GM-only group
of explants. Catalase activity was enhanced in DXM-only and
MLT-only treated explant groups compared to its activity in
the S explants (Figure 3B).
No difference was observed in levels of NO for all treat-
ment groups tested: i.e. S, GM-only, GM + DXM, GM + MLT,
GM + TCR treatment groups (Figure 3C). Consistent with
these NO results, exposure of organ of Corti to GM did not
affect the mRNA levels of the inducible form of NOS
(Figure 1E). DXM and MLT-only treated explants showed
higher levels of NO compared to S explant group values for
NO.
ROS detection. Organ of Corti explants exposed to GM only
experienced an increase in ROS compared with the S group of
explants in the base turn (Figure 4B and E), ROS was not
observed in the apex of the specimens (data not shown). The
mean of red signal intensity units (miu), corresponding to
CellROX Deep Red reagent for GM-only group was higher
than that of the S group in the auditory HCs and Deiter and
pillar cells, referred to as supporting cells (SCs-) of the base
(Figure 4P). A decrease in red signal intensity was observed
in the GM + DXM, GM + MLT and GM + TCR groups
(Figure 4H, K, N and P). The mean of red signal intensity was
higher in GM-exposed group of explants than in the S,
GM + DXM, GM + MLT and GM + TCR groups (Figure 4C, F,
I, L, O and Q).
Cleaved caspase-3 immunostaining. As shown in Figure 5P
and Q, there was a marked difference in the intensity of
immunofluorescent signal for cleaved (i.e. activated)
caspase-3 between GM-exposed organ of Corti explants and
the S, GM + DXM, GM + MLT and GM + TCR groups, in audi-
tory hair cells and supporting cells in the basal turn, while no
activation of this enzyme was detected in the apex area (data
not shown). Minimal activation of this apoptosis-associated
enzyme occurred in the hair cells and supporting cells of
organ of Corti explants treated with saline (S, Figure 5B and
C). In sharp contrast, there was a marked increase in activated
caspase-3 in the HCs and SCs of the GM-only exposed organ
of Corti cultures (GM, Figure 5E and F); they also showed
shrunken nuclei due to chromatin condensation and apop-
totic bodies representing breakdown of affected cell nuclei.
The auditory HCs and SCs in the GM + DXM, GM + MLT and
GM + TCR treated organ of Corti explants showed lower
levels of activated caspase-3 compared to the immunostain-
ing levels observed in the GM-only explants (compare
Figure 5H, I; K, L and N, O, respectively, with Figure 5E and
F). A high level of HC loss was observed in the organ of Corti
explants treated with GM-only (Figure 5D). Treatment of
GM-exposed explants with DXM, MLT and TCR resulted in a
reduction in the loss of HCs compared to that in the GM-only
explants (compare Figure 5G, J and M to 5D).
In vivo studies
DPgram. DPgrams corresponding to the different groups are
shown in Figure 6. For both of the local delivery systems
(Figure 6A and B), the cochleae treated with saline had
DPOAE values that were similar to the base line values that
were obtained before the onset of treatment. A decrease in
DPOAE values for the ears treated with GM was observed on
post-exposure days 10, 15 and 21 (Figure 6C and D). The
difference in DPgrams is significant at the higher frequencies,
that is, F2, 6000 to 10500 Hz, suggesting that the process of
surgery did not affect the auditory system and that it was the
GM-induced cochlear injury that was responsible for the
changes in thresholds. There were no significant differences
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between basal levels and DPOAE values for GM + DXM;
GM + MLT and GM + TCR groups of treatment in the gelfoam
delivery system; however, a decrease (ns; P > 0.05) in DPOAE
values was observed for the treatment groups in which GM
was delivered locally to the round window membrane niche
by the MPs (Figure 6F, H and J).
ABRs. The ABR threshold values in response to a click stimu-
lus presented in Figure 7 show that S-treated ears only
showed a significant elevation in threshold in the gelfoam
treatment group at 10 days post-treatment and then a return
to a pretreatment threshold at 15 days post-treatment
(Figure 7A and B), while cochleae treatment with GM by
either gelfoam or via a MP showed significant increases
(P < 0.05) in ABR threshold with respect to their baseline
values on post-treatment days 10–20 (Figure 7C and D). In
the GM + DXM (Figure 7E and F); GM + MLT (Figure 7G and
H) and GM + TCR (Figure 7I and J) treated groups, the ABR
threshold values were similar to those values recorded for the
S-treated ears with only a transient elevation in thresholds in
Figure 2
GM exposure of organ of Corti explants results in increases in the levels of phospho(p)-p38 MAPK and phospho(p)-JNK but did not affect the levels
of phospho(p)-ERK1/2. (A–C) ELISA assay results for the activation of three MAPK subfamilies with results presented as mean values  SD. (A) ERK
1/2 and p-ERK1/2, (B) p38 MAPK and p-p38 MAPK and (C) JNK and p-JNK in organ of Corti explants exposed to GM (GM) or saline (S) and treated
with DXM, MLT or TCR. In order to normalize the data obtained for each organ of Corti explant, the results are presented as the ratio of ELISA
absorbance at 450 nm/Bradford absorbance at 595 nm. Two-way ANOVA, in which the phosphorylated and non-phosphorylated form for each
enzyme were compared between groups was followed by Bonferroni test; n = 12 explants per group in duplicates; *P < 0.05, **P < 0.01,
***P < 0.001.
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Figure 3
GM exposure of organ of Corti explants causes a decrease in SOD and catalase activity. Treatment of GM-exposed explants with either DXM, MLT
or TCR protects the organ of Corti explants from GM-initiated free radical-induced oxidative stress. Histograms on the left present enzyme activity
levels in organ of Corti explant exposed to GM and treated individually with each of the three protective compounds in this study. Histograms
on the right present enzyme activity levels in organ of Corti explants treated with DXM, MLT or TCR-only in the absence of GM and compared
to the saline treated (S) explant group levels. Antioxidant enzyme activity levels corresponding to (A) SOD and (B) catalase. (C) iNOS activity levels
were addressed indirectly by measuring the levels of nitrite (NO2–), which is a primary, stable and non-volatile breakdown product of NO. In order
to normalize the data obtained for each experiment, the results are presented in the case of SOD and catalase as the ratio of units of each enzyme
activity/mg of total protein. In the case of iNOS, activity levels are presented as the ratio of concentration of NO2-mg-1 of total protein. One-way
ANOVA followed by Bonferroni test; n = 6 explants per group in duplicates; *P < 0.05, **P < 0.01, ***P < 0.001.
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Figure 4
Organ of Corti explants exposed to GM (D–F) experienced an increase in ROS compared with the S-treated group of explants (A–C), and those
exposed to GM + treated with DXM (G–I), MLT (J–L) or TCR (M–O) in the basal turn area of the explants. Treatment of GM-exposed explants with
DXM, MLT and TCR resulted in a reduction in the loss of hair cells compared to GM-only explants (compare G, J and M to D). Bars in all
pictures = 25 mm. The photomicrographs in A–O are representative of the results obtained from six explants per treatment group. (P and Q) shows
differences in the mean signal intensity in the red channel for auditory hair cells and supporting cells, respectively, for the saline (S) control and
the four treatment groups (mean values  SD). One-way ANOVA followed by Bonferroni test; n = 6 explants per group; *P < 0.05, **P < 0.01.
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the MP GM + DXM group at 10 days and in the MP
GM + TCR group at 15 days post-treatment.
Cytocochleogram. Analysis of the cochleograms constructed
from the hair cell counts taken from the organ of Corti
FITC-phalloidin-stained surface preparations from the five
groups of animals (Figure 8) indicate a loss of OHCs in the
mid- to high-frequency regions (i.e. 55 to 100% from the
apex) of the cochleae treated with GM while the cochleae
treated with saline lost very few auditory sensory cells. Treat-
ment of cochleae with GM did not affect IHCs viability (data
not shown). In the mid- to high-frequency regions, the treat-
ment of GM-exposed cochleae with either DXM, MLT or TCR
prevented most of the GM exposure-induced OHC losses.
Discussion
Oxidative stress
Several reports have concluded that the generation of ROS is
linked to the ototoxicity of aminoglycosides, probably due to
the ability of ROS to promote apoptotic and/or necrotic cell
death of hair cells (Ylikoski et al., 2002; Rybak and Ramku-
mar, 2007; Cunningham and Tan, 2011). Choung et al.
(2009) observed in GM-challenged organ of Corti explants
that the formation of highly reactive oxygen species (hROS)
was most prominent within the OHCs and showed both a
base to apex as well as a first to the third row of OHCs
intensity gradient. Moreover, they observed that patterns of
stereocilia loss correlated with the accumulation pattern of
hROS within hair cells of the GM-exposed explants. Our
results demonstrate that GM treatment of organ of Corti
explants increases the levels of ROS and also decreases the
activity levels of the enzymes SOD (an important intracellular
antioxidant enzyme) and catalase, which protects against
H2O2. Treatment of GM-exposed explants with DXM, MLT
and TCR reduced the levels of ROS production, but only DXM
and MLT promoted an increase in the levels of SOD and
catalase. These results suggest that the tested compounds
reduce the levels of ROS in the HCs by increasing the activity
of existing enzymes, such as SOD and catalase. Reactive nitro-
gen species are also known to be involved in cochlear injury
induced by GM (Xie et al., 2011). Heinrich et al. (2008) dem-
onstrated that GM caused hearing loss in association with an
increase in NO production by the cochlea’s lateral wall tissues
and organ of Corti of guinea pigs. However, a study by
Nordang and Anniko (2005) showed that the NO inhibitor
L-nitro-arginine methyl ester (L-NAME) can provide only
moderate otoprotection against GM-induced HC and hearing
losses. Based on our results, the lack of an iNOS response by
GM-exposed explants or by any of the treatments groups,
clearly demonstrate that iNOS does not play a major role in
GM ototoxicity. Because iNOS transcription remained at a
basal level, the increase in NO in DXM-only and MLT-only
treated explant groups could be due to an increase in endot-
helial NOS and/or neuronal NOS.
MAPK signalling
One signalling enzyme activated by aminoglycoside exposure
via production of ROS is JNK, which has been shown to
contribute to the initiation of apoptosis of damaged cells
(Davis, 2000). While Kalinec et al. (2005) reported that gen-
tamicin ototoxicity was mediated by the inhibition of JNK
pathway and that a weak and transient activation happened
mainly in supporting cells, Pirvola et al. (2000) and Ylikoski
et al. (2002) found that JNK signalling was activated in audi-
tory HCs after exposure to either an ototoxic antibiotic or a
damaging level of noise. In this context, Van De Water and
colleagues (Eshraghi et al., 2007) demonstrated that hearing
loss induced by either exposure to an ototoxic antibiotic or
mechanical trauma caused during cochlear implantation can
be prevented by blocking JNK signalling with local adminis-
tration of the inhibitory peptide, that is, D-JNKI-1. In this
study, we showed that treatment with GM produces an
increase in phosphorylated JNK and that treatment with all
three compounds tested (i.e. DXM, MLT and TCR) lowered
phospho-JNK levels.
Phospho-p38 levels, which are known to control cellular
responses to stress and pro-inflammatory cytokines, were sig-
nificantly reduced in the OC treated with MLT or TCR. Lahne
and Gale (2008) reported the activation of ERK1/2 in support-
ing cells surrounding pyknotic HC nuclei in the neomycin-
exposed organ of Corti, suggesting that ERK signalling
promotes HC death and indicating a direct role for support-
ing cells in the regulation of HC death. In our study, DXM
and MLT treatment of GM-exposed explants increased the
levels of phosphorylated-ERK1/2, which can phosphorylate
and activate the transcription factors, for example, Elk-1,
c-fos and c-myc, thereby increasing a stressed cell’s ability to
survive (Hipskind et al., 1991). However, since in this study,
the levels of ERK1/2 and the activated form of this kinase
Figure 4
Continued.
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Figure 5
GM exposure of organ of Corti explants initiated the activation of caspase-3 in both auditory hair cells and supporting cells. This activation of
pro-caspase-3 into an active form was prevented by the treatment of the GM-challenged explants with either DXM, MLT or TCR (G–O). Explant
treatment groups: (A–C) saline (S) control; (D–F) GM, gentamicin-only treated; (G–I) GM + DXM, gentamicin and dexamethasone treated; (J–L)
GM + MLT, gentamicin and melatonin treated; and (M–O) GM + TCR, gentamicin and tacrolimus treated. Phalloidin-FITC stain, green (A, D, G,
J, M); anti-activated caspase-3, TRITC, red combined with DAPI, blue (B–C, E–F, H–I, K–L, N–O), bars in all pictures = 25 mm. The photomicro-
graphs presented in A–O are representative of the results obtained from the six explants per treatment group. Treatment of GM-exposed explants
with DXM, MLT and TCR resulted in a reduction in the loss of hair cells compared to GM-only explants (compare G, J and M to D). (P and Q)
shows differences in the mean signal intensity in the red channel for auditory hair cells and supporting cells, respectively, for the S control explants
and for the four experimental groups of this study. One-way ANOVA followed by Bonferroni test; n = 6 explants per group; *P < 0.05, **P < 0.01,
***P < 0.001.
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were measured in whole OC, it is not possible to determine if
the ERK activation occurred in the supporting cells, as
reported by Lahne and Gale (2008).
Pro-inflammatory cytokines
So et al. (2007) reported that ROS are formed in response to
trauma, which in the present study, was caused by exposure
to GM. GM exposure produces high levels of ROS and an
inflammatory response where the phosphorylation of p38
MAPK and JNK play important roles in the stress-related loss
of auditory HCs (Op de Beck et al., 2011). Our results show
that exposure of explants to GM results in increased levels of
TNF-a, IL-1b and TNFRSF1A expression. We also showed that
DXM treatment of GM-exposed explants down-regulated the
expression of both of these pro-inflammatory cytokines and
TNFRSF1A. DXM treatment of the GM-exposed explants did
not reduce the level of IL1R1 transcripts, while DXM-only
treated explants had increased mRNA levels for this cytokine
receptor. MacGillivray et al. (2000) reported that IL-1b can
induce the activation of ERK through its receptor, that is,
IL1R1. This observation could explain the correlation we
observed between IL1R1 mRNA up-regulation and higher
levels of phospho-ERK1/2 in the DXM-only treated group.
Treatment of GM-exposed explants with MLT resulted in sig-
nificant down-regulation of TNF-a and TNFRSF1A expression,
while MLT had no significant effect on IL-1b and IL1R1
expression in GM-exposed explants. In contrast, MLT-only
treatment of explants initiated an increase in the expression
of IL-1b mRNA, which correlates with an increase in the levels
of the phosphorylated form of ERK1/2, p-38 MAPK and JNK,
although none were significantly different from their acti-
vated forms in the S-treated explants.
MLT treatment
Treatment of rats with MLT protected against GM-induced
ototoxicity as shown by the auditory function results and by
the histological assays of HCs present in the cytocochleo-
grams. These findings are in accord with Ye et al. (2009), who
observed that MLT attenuated HC loss caused by exposure
of guinea pigs to an ototoxic level of gentamicin. MLT
has previously been demonstrated to have both anti-
inflammatory and neuroprotective properties by reducing
IL-1b and TNF-a levels and by inhibiting the phosphoryla-
tion of p38, JNK and ERK1/2 in a spinal cord injury model
(SCI; Esposito et al., 2009). The differences in phosphoryla-
tion levels obtained for ERK1/2 in the present study may be
explained by the fact that our model is not limited to neu-
rones, since the organ of Corti explant is a complex structure
composed of several different kinds of HCs and SCs. In con-
trast, Joo and Yoo (2009) reported MLT induced apoptosis in
an androgen-sensitive human prostate adenocarcinoma cell
line [i.e. lymph node carcinoma of the prostate (LNCaP)] via
JNK and p38, but not ERK signalling. The present study indi-
cates an anti-apoptotic effect of MLT, since treatment of
GM-exposed explants with MLT inhibited the activation of
caspase-3 and HC death. In this context and according to our
findings, Kim et al. (2009) reported the protective effect of
MLT treatment in GM-exposed utricular explants was as a
result of an inhibitory effect on both ROS production and
caspase-3 activation.
DXM treatment
DXM is known to inhibit AP-1 activity (González et al., 2000).
Local administration of DXM into the inner ear has been
shown to be otoprotective when applied before the adminis-
tration of an aminoglycoside with a loop diuretic; however,
only mild protection occurred when DXM was applied after
exposure to an aminoglycoside (Himeno et al., 2002). Dinh
et al. (2008) reported the otoprotective properties of DXM
against TNF-a in organ of Corti explants demonstrating an
up-regulation of both Bcl-2 and Bcl-xl and inhibition of Bax
expression that resulted in a lowering of the Bax/Bcl-2 expres-
sion ratio favouring HC survival. Our adult rat results indicate
that local DXM treatment prevented both loss of auditory
function and loss of their HCs in GM-exposed rats.
Figure 5
Continued.
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Figure 6
GM exposure causes a loss in the intensity of the DPOAEs (thought to reflect a loss of outer hair cell function) while local treatment with either
DXM, MLT or TCR protected against this GM-induced loss of DPOAE intensity. DPOAEs for gelfoam (left column) and MP (right column) of animals
treated with saline (S) (A, B); GM (C, D); GM + DXM (E, F); GM + MLT (G, H); and GM + TCR (I, J). In each graph, the symbols correspond to
untreated, 10 days post-treatment, 15 days post-treatment and 20 days post-treatment values. Error bars show SD; two-way ANOVA, Bonferroni’s
test; n = 5 animals per group; *P < 0.05, **P < 0.01.
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Figure 6
See caption on previous page.
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Figure 7
See caption on next page.
BJPProtection from gentamicin-induced hair cell and hearing loss
British Journal of Pharmacology (2012) 166 1888–1904 1901
TCR treatment
TCR is a potent immunosuppressive drug primarily used for
the reduction of allograft rejection and has been reported to
be neuroprotective following CNS injury. Our results indicate
that local delivery of TCR via the round window membrane
of the GM-exposed rat cochlea prevented both HC loss and
an increase in hearing threshold levels (i.e. hearing loss) that
occurred in the GM-only treated animals. Guzmán-Lenis
et al. (2008) demonstrated that TCR had a significant protec-
tive effect on spinal cord tissue following acute excitotoxic
damage that was characterized by a release of pro-
inflammatory cytokines, such as TNF-a and IL-1b, which are
mainly produced and released by microglia. In this context,
Saganová et al. (2009) mentioned that immunosuppressant
drugs, including TCR, have direct inhibitory effects on micro-
glia by inhibiting microglial secretion of neurotoxic sub-
stances such as pro-inflammatory cytokines and NO. Our in
vitro results showed a significant inhibition of gene expres-
sion for TNFRSF1A occurred in the GM-exposed TCR-treated
explants with no significant effect on the expression of TNF-a
or IL-1b and its receptor, IL1R1. Therefore, the in vitro results
obtainedfor TCR treatment of GM-exposed explants provides
weak support for a possible immunosuppressive action by
TCR to explain its in vivo otoprotection.
Clinical implications
All three of the compounds tested have been used clinically
and all have been shown to be effective at protecting against
GM ototoxicity both in vitro and in vivo. However, only local
application, via the round window membrane, of one of
these compounds, DXM, has been extensively used to treat
hearing (Haynes et al., 2007). Therefore, this would be the
drug of first choice in an attempt to limit the damage that
can result from systemic therapy with an aminoglycoside
antibiotic.
Conclusions
The development of local long-term delivery techniques to
the cochlea will be a breakthrough in terms of reducing the
levels of drugs required for effective treatment, decreasing or
eliminating side effects and avoiding alteration of drugs by
liver metabolism, thereby assuring that the desired concen-
tration of a drug is achieved only in the target area, that is,
the perilymph within the scala tympani. The results of our
study show that local treatment of the cochlea with DXM,
MLT or TCR can conserve auditory function and prevent HC
loss.
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